Jotin Marango - 19 Aug 2021 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Senior VP, CFO, and CBO
Signature
/s/ Janet Clennett as attorney-in-fact for Jotin Marango
Issuer symbol
APTOF
Transactions as of
19 Aug 2021
Net transactions value
$0
Form type
4
Filing time
23 Aug 2021, 16:57:37 UTC
Next filing
20 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Performance Stock Option Award $0 +200,000 $0.000000 200,000 19 Aug 2021 Common Shares 200,000 $2.35 Direct F1, F2
transaction APTO Performance Stock Option Award $0 +200,000 $0.000000 200,000 19 Aug 2021 Common Shares 200,000 $2.35 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on August 19, 2021 and vest upon the earlier of (i) certain performance conditions or (ii) August 19, 2025, subject to Reporting Person's continued employment with the Issuer.
F2 Options vest in tranches connected with financing events.
F3 Options vest in connection with licensing and partnering events.